
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.440 | 1.440 | 0.000 |
Shares | 98.560 | 98.560 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.479 | 18.217 |
Price to Book | 3.311 | 3.356 |
Price to Sales | 2.289 | 2.188 |
Price to Cash Flow | 14.167 | 13.498 |
Dividend Yield | 3.163 | 2.930 |
5 Years Earnings Growth | 8.444 | 8.962 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 36.200 | 30.702 |
Financial Services | 27.070 | 21.709 |
Consumer Defensive | 16.820 | 12.677 |
Industrials | 11.070 | 15.914 |
Consumer Cyclical | 5.470 | 5.298 |
Technology | 3.380 | 3.448 |
Number of long holdings: 33
Number of short holdings: 10
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 15.34 | 74.99 | -0.41% | |
Roche Holding Participation | CH0012032048 | 14.01 | 286.20 | -1.34% | |
Novartis | CH0012005267 | 10.89 | 104.04 | -0.44% | |
UBS Group | CH0244767585 | 7.48 | 31.80 | -2.09% | |
Zurich Insurance Group | CH0011075394 | 7.17 | 577.60 | +1.55% | |
Swiss Re | CH0126881561 | 5.91 | 150.25 | +0.33% | |
ABB | CH0012221716 | 5.20 | 58.56 | -0.27% | |
Richemont | CH0210483332 | 4.15 | 151.00 | -1.11% | |
Lonza Group | CH0013841017 | 3.65 | 523.40 | -1.13% | |
Swiss Life Holding | CH0014852781 | 3.06 | 881.60 | +1.75% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0429081638 | 7.99B | 0.65 | 9.70 | - | ||
CH0429081620 | 7.99B | -5.55 | 7.85 | - | ||
CH0337393745 | 6.52B | -5.65 | 7.60 | - | ||
CSIF CH Emerging Markets Index Blue | 3.63B | 12.53 | 10.30 | 5.88 | ||
CH0017844686 | 3.63B | 12.46 | 10.21 | 5.79 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review